EANS-DD: AGENNIX AG
Notification concerning transactions by persons performing
managerial responsibilities pursuant to section 15a of the WpHG
-------------------------------------------------------------------------------- Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------
Details of the person subject to the disclosure requirement: --------------------------------------------------------------------------------
Person, triggering the disclosure:
-----------------------------
Name: dievini Hopp BioTech holding GmbH & Co. KG
(Legal person, company or institution)Reason for the disclosure requirement: ------------------------------ Reason: Legal person, company or institution closely associated Relationship: To a person performing managerial responsibilities
Person performing managerial responsibilities, triggering the disclosure requirement:
--------------------------------------------------------------------------------
Position: Member of an administrative or supervisory body
Details of the transaction:
--------------------------------------------------------------------------------
Transaction:
------------
Description of financial instrument: Non-par value ordinary bearer shares
ISIN: DE000A1A6XX4
Type of transaction: Subscription pursuant to firm commitment agreement
Date: 01.10.2010
Currency: Euro
Price: 3.81000
No of items: 14053737
Total amount traded: 53,544,737.97000
Place: Over the counter
Explanation: Pursuant to the firm commitment agreement of September 14,
2010 dievini Hopp BioTech holding GmbH & Co. KG has
subscribed to all shares issued in connection with the
capital increase resolved upon by the annual general
meeting on May 25, 2010 that were not subscribed to by the
shareholders of Agennix AG or new investors.
The subscription commitment by dievini Hopp BioTech holding
GmbH & Co. KG is attributed to members of the managing and
supervisoring bodies (Prof. von Bohlen und Halbach as a
member of the Management Board and Prof. Hettich as a
member of the Supervisory Board).Further inquiry note: ----------------- Investor Relations & Corporate Communications Tel.: +49 (0) 89 8565 2693 E-Mail: ir@agennix.com
Issuer subject to the publication requirement: --------------------------------------------------------------------------------
end of announcement euro adhoc --------------------------------------------------------------------------------
Further inquiry note:
Branche: Pharmaceuticals
ISIN: DE000A1A6XX4
WKN: A1A6XX
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade
Original-Content von: AGENNIX AG i.L., übermittelt durch news aktuell